Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA says Lilly weight loss drug shortage is over
In weight loss battle, Novo and Lilly face growing offensive from licensed copies
As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented remedies are winning approval from some regulators overseas, posing a threat to the pharma giants' prices and market share.
FDA says Lilly weight loss drug shortage is over after taking a second look
The FDA said Thursday it’s standing by its earlier decision that the shortage of tirzepatide — the active ingredient in Eli Lilly’s diabetes and weight loss drugs Mounjaro and Zepbound — is over.
Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?
The weight-loss drugs battle has grabbed Wall Street's attention and stoked shares of Eli Lilly and Novo Nordisk. But others are coming.
15d
Could Eli Lilly Beat Rivals in the Billion-Dollar Weight Loss Drug Market in 2025? Evidence Is Piling Up, and Here's What It Says.
Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
USA Today
18d
Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial
Eli
Lilly
said on Wednesday patients ... while Wegovy led to a 15%
weight
loss
after 68 weeks. Doctors had been prescribing these
drugs
based on whichever was available to patients at the ...
Benefits Pro
4d
Eli Lilly expands access to weight loss drug Zepbound
Eli
Lilly
headquarters located in Indianapolis, Indiana. Although the GLP-1 drug Zepbound has been shown to be effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
MLB's stolen base king dies
Biden signs funding bill
Mass exodus of players
Social Security bill approved
Top NYPD officer resigns
'Snowfall' writer dies at 32
US ambassador to Italy
RFK Stadium bill passed
Blake Lively sues Baldoni
MO abortion ban blocked
Russian fuel depot targeted
100 salmonella cases linked
US hits Houthi sites
Brazil bus crash: 38 dead
Special envoy to the UK
Proposes contract changes
Usyk defeats Fury again
Reverses Ohio layoffs
Nic Claxton fined $25K
NBA fines Celtics coach
Egg prices hit record
8 convicted in Paty murder
Child car seats recall
Military chopper catches fire
GMU student charged
Netflix inks deal with FIFA
To wind down operations
Zepbound OK'd for apnea
New rules for self-driving
US charges Iranian officer
Trudeau reshuffles cabinet
Threatens EU with tariffs
US kills ISIS leader
Related topics
Zepbound
United States
Novo Nordisk
Feedback